Immunomedics (IMMU) Short Interest Ratio & Short Volume → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free IMMU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Immunomedics Short Interest DataCurrent Short Volume23,600,000 sharesPrevious Short Volume26,650,000 sharesChange Vs. Previous Month-11.44%Dollar Volume Sold Short$2.01 billionShort Interest Ratio / Days to Cover0.0Last Record DateSeptember 30, 2020Outstanding Shares231,144,000 sharesPercentage of Shares Shorted10.21%Today's Trading Volume0 sharesAverage Trading Volume4,013,131 sharesToday's Volume Vs. Average0% Short Selling Immunomedics ? Sign up to receive the latest short interest report for Immunomedics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMMU Short Interest Over TimeIMMU Days to Cover Over TimeIMMU Percentage of Float Shorted Over Time Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... Immunomedics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/202023,600,000 shares $2.01 billion -11.4%N/A0 $85.03 9/15/202026,650,000 shares $2.26 billion +2.4%N/A6.1 $84.75 8/31/202026,030,000 shares $1.16 billion -1.0%N/A10.1 $44.56 8/14/202026,290,000 shares $1.05 billion -0.7%N/A9.4 $40.00 7/31/202026,470,000 shares $1.12 billion -1.5%N/A8.7 $42.23 7/15/202026,870,000 shares $1.11 billion +1.6%N/A6.5 $41.16 Get the Latest News and Ratings for IMMU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunomedics and its competitors with MarketBeat's FREE daily newsletter. 6/30/202026,440,000 shares $905.04 million -10.2%N/A5.9 $34.23 6/15/202029,430,000 shares $922.34 million +1.8%N/A5.8 $31.34 5/29/202028,920,000 shares $971.42 million -1.1%N/A5.6 $33.59 5/15/202029,240,000 shares $992.99 million +3.5%N/A5.8 $33.96 4/30/202028,260,000 shares $858.54 million -10.3%N/A6 $30.38 4/15/202031,490,000 shares $627.28 million +8.0%N/A7.7 $19.92 3/31/202029,150,000 shares $392.94 million +9.1%N/A8.7 $13.48 3/13/202026,724,800 shares $339.40 million -1.4%N/A12.6 $12.70 2/28/202027,090,000 shares $433.44 million -0.7%N/A13.7 $16.00 2/14/202027,270,000 shares $500.68 million +0.2%N/A13 $18.36 1/31/202027,220,000 shares $505.48 million +2.5%N/A12.8 $18.57 1/15/202026,550,000 shares $519.58 million +5.3%N/A12 $19.57 12/31/201925,220,000 shares $533.66 million -2.4%N/A11.6 $21.16 11/15/201929,940,000 shares $530.84 million -5.5%16.5%13.5 $17.73 IMMU Short Interest - Frequently Asked Questions What is Immunomedics' current short interest? Short interest is the volume of Immunomedics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 23,600,000 shares of IMMU short. Learn More on Immunomedics' current short interest. Is Immunomedics' short interest increasing or decreasing? Immunomedics saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 23,600,000 shares, a decline of 11.4% from the previous total of 26,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Immunomedics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Immunomedics: Lantheus Holdings, Inc. (6.95%), Neogen Co. (8.15%), QuidelOrtho Co. (4.05%), Celldex Therapeutics, Inc. (12.08%), Intellia Therapeutics, Inc. (15.13%), Myriad Genetics, Inc. (6.08%), IDEXX Laboratories, Inc. (2.08%), STERIS plc (2.50%), Illumina, Inc. (3.31%), Baxter International Inc. (1.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.91 billion), Aon plc ($3.68 billion), The Clorox Company ($2.92 billion), Analog Devices, Inc. ($2.35 billion), Uber Technologies, Inc. ($2.27 billion), Moderna, Inc. ($2.14 billion), The Kroger Co. ($2.14 billion), Datadog, Inc. ($2.00 billion), Simon Property Group, Inc. ($1.85 billion), and International Flavors & Fragrances Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Immunomedics stock? Short selling IMMU is an investing strategy that aims to generate trading profit from Immunomedics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunomedics? A short squeeze for Immunomedics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMMU, which in turn drives the price of the stock up even further. How often is Immunomedics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMMU, twice per month. The most recent reporting period available is September, 30 2020. More Short Interest Resources from MarketBeat Related Companies: Lantheus Short Squeeze Neogen Short Squeeze QuidelOrtho Short Squeeze Celldex Therapeutics Short Squeeze Intellia Therapeutics Short Squeeze Myriad Genetics Short Squeeze IDEXX Laboratories Short Squeeze STERIS Short Squeeze Illumina Short Squeeze Baxter International Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMMU) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders